AU2001235894A1 - Novel mammalian secreted group iii phospholipase a2 - Google Patents

Novel mammalian secreted group iii phospholipase a2

Info

Publication number
AU2001235894A1
AU2001235894A1 AU2001235894A AU3589401A AU2001235894A1 AU 2001235894 A1 AU2001235894 A1 AU 2001235894A1 AU 2001235894 A AU2001235894 A AU 2001235894A AU 3589401 A AU3589401 A AU 3589401A AU 2001235894 A1 AU2001235894 A1 AU 2001235894A1
Authority
AU
Australia
Prior art keywords
group iii
secreted group
novel mammalian
mammalian secreted
spla2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001235894A
Inventor
Gerard Lambeau
Michel Lazdunski
Emmanuel Valentin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Publication of AU2001235894A1 publication Critical patent/AU2001235894A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention concerns DNA and peptide sequence encoding a mammalian secreted group III sPLA2 and more particularly a human secreted group III (hGIII) sPLA2. The invention also concerns the use of this secreted group III sPLA2 in methods for screening various chemical compounds.
AU2001235894A 2000-02-11 2001-02-09 Novel mammalian secreted group iii phospholipase a2 Abandoned AU2001235894A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18176500P 2000-02-11 2000-02-11
US60181765 2000-02-11
US09781100 2001-02-09
PCT/IB2001/000270 WO2001059129A2 (en) 2000-02-11 2001-02-09 Mammalian secreted group iii phospholipase a2
US09/781,100 US6875599B2 (en) 2000-02-11 2001-02-09 Mammalian secreted group III phospholipase A2

Publications (1)

Publication Number Publication Date
AU2001235894A1 true AU2001235894A1 (en) 2001-08-20

Family

ID=26877495

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001235894A Abandoned AU2001235894A1 (en) 2000-02-11 2001-02-09 Novel mammalian secreted group iii phospholipase a2

Country Status (9)

Country Link
US (1) US6875599B2 (en)
EP (1) EP1254239B1 (en)
JP (1) JP4758585B2 (en)
AT (1) ATE378410T1 (en)
AU (1) AU2001235894A1 (en)
CA (1) CA2399910C (en)
DE (1) DE60131372T2 (en)
ES (1) ES2295134T3 (en)
WO (1) WO2001059129A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040011895A (en) * 2002-07-31 2004-02-11 김대경 Novel Ca2+ independent phospholipase A2, iPLA2,in bovine brain and its use and the preparation method thereof
EP1658498A1 (en) * 2003-08-20 2006-05-24 Celltech R & D Limited Methods for obtaining antibodies
WO2007045660A1 (en) * 2005-10-19 2007-04-26 Novartis Ag Group iii secretory phospholipase a2 (spla2-iii) for therapy and diagnosis
CN102427825A (en) * 2009-03-24 2012-04-25 约瑟夫·傅立叶大学 Fertilization modulation compounds and process for implementing them
KR101039403B1 (en) 2009-08-10 2011-06-08 동아대학교 산학협력단 Nucleotide sequence of phospholipase A2 gene from the venom of the bumblebee Bombus ignitus
US10076833B2 (en) 2013-10-10 2018-09-18 Makita Corporation Electric tools

Also Published As

Publication number Publication date
CA2399910C (en) 2009-06-16
JP2003522529A (en) 2003-07-29
DE60131372T2 (en) 2008-09-04
US20020037572A1 (en) 2002-03-28
CA2399910A1 (en) 2001-08-16
EP1254239A2 (en) 2002-11-06
ATE378410T1 (en) 2007-11-15
EP1254239B1 (en) 2007-11-14
JP4758585B2 (en) 2011-08-31
US6875599B2 (en) 2005-04-05
DE60131372D1 (en) 2007-12-27
ES2295134T3 (en) 2008-04-16
WO2001059129A2 (en) 2001-08-16
WO2001059129A3 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
EP1451297A4 (en) Phenotypic screen of chimeric proteins
AU2002341920A1 (en) Chemical compounds
EP0731636A4 (en) Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
WO2002102828A3 (en) Chimeric flavivirus vectors
AU1595097A (en) Synthetic test soil
AU2001262906A1 (en) Peptide biosensors for anthrax protease
AU2002217010A1 (en) Peptides, the production and use thereof for binding immunoglobulins
IL145689A0 (en) Methods
AU2001235894A1 (en) Novel mammalian secreted group iii phospholipase a2
AU2001263269A1 (en) Long wavelength engineered fluorescent proteins
AU2001268951A1 (en) Modulators of protein tyrosine phosphatases (ptpases)
AU4261901A (en) Quantitative analysis of biological images
WO2002026929A3 (en) Kini-3 motor protein and methods for its use
AU1183200A (en) Novel gene encoding brain-specific membrane protein
SG185137A1 (en) Biologically active peptides
AU2002218460A1 (en) Transportation of biological specimens
AU2002232016A1 (en) Method of isolating charged compounds, especially peptides and proteins
WO2002012541A3 (en) Novel motor proteins and methods for their use
WO2001096593A3 (en) Novel motor proteins and methods for their use
WO2002031127A3 (en) Cloning and recombinant expression of mammalian group xii secreted phospholipase a¿2?
WO2001087932A3 (en) Seven transmembrane proteins and polynucleotides encoding the same
WO2002079479A3 (en) Motor proteins and methods for their use
AU2001286091A1 (en) Methods for identifying modulators of protein interactions
WO2001094417A3 (en) Novel human seven transmembrane proteins and polynucleotides encoding the same
WO2002042451A3 (en) Aspergillus fumigatus cofilin